CVS, Walgreens to Offer Abortion Pill Mifepristone in Select States

The move follows a 2023 FDA decision, marking a significant development in the ongoing debate over reproductive rights.

CVS and Walgreens will start selling the abortion pill mifepristone in some US states, following a 2023 FDA decision.
The move is hailed by President Biden as an important milestone for reproductive freedom amid ongoing political debates.
The Supreme Court is set to hear a case on limiting access to mifepristone, with implications for the upcoming election.
Medication abortion, which includes mifepristone, is the most common method of abortion in the US.
Critics argue the FDA has abandoned its responsibility to protect life, while supporters highlight the safety and effectiveness of the drug.